Release Details

SAN DIEGO, Feb. 25 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will be presenting at Lehman Brothers 5th Annual Global Healthcare Conference being held in Orlando, Florida on Tuesday, February 26, 2002 at 7:15AM Pacific Time (10:15AM Eastern Time). To hear the live presentation, please dial 1-800-553-3587 (US) or 1-303-713-7920 (International) and reference Neurocrine's ID #1560904.

Gary Lyons, President and CEO of Neurocrine will present an update on the Company's insomnia program and will highlight Neurocrine's research and development pipeline. If you are unable to listen to the live presentation, it will be archived for seven days and can be accessed by dialing 1-800-625-5288 (US) or 1-303-804-1855 (International) referencing Neurocrine's ID #1560904. If you would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders.

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .

    Contact:  Claudia Jones at 858-658-7600

                     MAKE YOUR OPINION COUNT - Click Here
               http://tbutton.prnewswire.com/prn/11690X23826681

SOURCE Neurocrine Biosciences, Inc.
Web site: http: //www.neurocrine.com
CONTACT: Claudia Jones or Paul Hawran, both of Neurocrine Biosciences, Inc., +1-858-658-7600